130 related articles for article (PubMed ID: 38197397)
1. Nanoparticle-mediated active and passive drug targeting in oral squamous cell carcinoma: current trends and advances.
Manikkath J; Manikkath A; Lad H; Vora LK; Mudgal J; Shenoy RR; Ashili S; Radhakrishnan R
Nanomedicine (Lond); 2023 Nov; 18(27):2061-2080. PubMed ID: 38197397
[TBL] [Abstract][Full Text] [Related]
2. A Targeted and pH-Responsive Nano-Graphene Oxide Nanoparticle Loaded with Doxorubicin for Synergetic Chemo-Photothermal Therapy of Oral Squamous Cell Carcinoma.
Li R; Liu C; Wan C; Liu T; Zhang R; Du J; Wang X; Jiao X; Gao R; Li B
Int J Nanomedicine; 2023; 18():3309-3324. PubMed ID: 37351329
[TBL] [Abstract][Full Text] [Related]
3. Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature.
Cao M; Shi E; Wang H; Mao L; Wu Q; Li X; Liang Y; Yang X; Wang Y; Li C
Int J Nanomedicine; 2022; 17():4293-4306. PubMed ID: 36134201
[TBL] [Abstract][Full Text] [Related]
4. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
5. Current trends of targeted therapy for oral squamous cell carcinoma.
Li H; Zhang Y; Xu M; Yang D
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2169-2186. PubMed ID: 35501496
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas.
Wang X; Li S; Liu H
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102218. PubMed ID: 33592329
[TBL] [Abstract][Full Text] [Related]
7. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential.
Meng X; Lou QY; Yang WY; Wang YR; Chen R; Wang L; Xu T; Zhang L
Cancer Commun (Lond); 2021 Oct; 41(10):981-1006. PubMed ID: 34289530
[TBL] [Abstract][Full Text] [Related]
8. The selective toxicity of superparamagnetic iron oxide nanoparticles (SPIONs) on oral squamous cell carcinoma (OSCC) by targeting their mitochondria.
Afrasiabi M; Seydi E; Rahimi S; Tahmasebi G; Jahanbani J; Pourahmad J
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-8. PubMed ID: 33704875
[TBL] [Abstract][Full Text] [Related]
9. Combined Photothermotherapy and Chemotherapy of Oral Squamous Cell Carcinoma Guided by Multifunctional Nanomaterials Enhanced Photoacoustic Tomography.
Zeng S; Liu S; Lan Y; Qiu T; Zhou M; Gao W; Huang W; Ge L; Zhang J
Int J Nanomedicine; 2021; 16():7373-7390. PubMed ID: 34754191
[TBL] [Abstract][Full Text] [Related]
10. Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy.
Gharat SA; Momin M; Bhavsar C
Crit Rev Ther Drug Carrier Syst; 2016; 33(4):363-400. PubMed ID: 27910740
[TBL] [Abstract][Full Text] [Related]
11. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
Yang M; Luo Q; Chen X; Chen F
J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
[TBL] [Abstract][Full Text] [Related]
12. PEGylated doxorubicin nanoparticles mediated by HN-1 peptide for targeted treatment of oral squamous cell carcinoma.
Wang Y; Wan G; Li Z; Shi S; Chen B; Li C; Zhang L; Wang Y
Int J Pharm; 2017 Jun; 525(1):21-31. PubMed ID: 28412450
[TBL] [Abstract][Full Text] [Related]
13. Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.
Tao Y; Liu Y; Dong Z; Chen X; Wang Y; Li T; Li J; Zang S; He X; Chen D; Zhao Z; Li M
ACS Appl Mater Interfaces; 2022 Oct; 14(39):44039-44053. PubMed ID: 36153957
[TBL] [Abstract][Full Text] [Related]
14. MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.
Zhang X; Han Y; Liu S; Guo B; Xu S; He Y; Liu L
Cell Mol Biol Lett; 2022 Dec; 27(1):107. PubMed ID: 36474192
[TBL] [Abstract][Full Text] [Related]
15. Effectual nanotherapy against oral squamous cell carcinoma.
Bharadwaj R; Medhi S
Drug Dev Ind Pharm; 2021 May; 47(5):711-724. PubMed ID: 34030522
[TBL] [Abstract][Full Text] [Related]
16. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ
J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma.
Elsaady SA; Aboushelib MN; Al-Wakeel E; Badawi MF
Sci Rep; 2023 Jul; 13(1):11984. PubMed ID: 37491569
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared-responsive GE11-CuS@Gal nanoparticles as an intelligent drug release system for targeting therapy against oral squamous cell carcinoma.
Lan Q; Wang S; Chen Z; Hua J; Hu J; Luo S; Xu Y
Int J Pharm; 2024 Jan; 649():123667. PubMed ID: 38048890
[TBL] [Abstract][Full Text] [Related]
20. Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
Khiavi MM; Abdal K; Abbasi MM; Hamishehkar H; Aghbali AA; Salehi R; Sina M; Abdollahi B; Fotohi S
Indian J Med Res; 2017 Jan; 145(1):112-117. PubMed ID: 28574023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
